Evidence map›Paper›PMID 29744671›Full record

ArticleJournal of gastrointestinal cancer2019

Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001-2015.

Rahmatollah Moradzadeh, Parvaneh Golmohammadi, Bahman Ghaitasi, Haidar Nadrian, Athareh Najafi

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Trend of gastric cancer in a province in Western Iran: A population-based study during 2001-2014.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020
    Article
  11. Worldwide trends in breast cancer incidence from 1993 to 2012: Age-period-cohort analysis and joinpoint regression.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rahmatollah MoradzadehDepartment of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.
Parvaneh GolmohammadiDepartment of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.
Bahman GhaitasiCancer Registry, Kurdistan University of Medical Sciences, Cancer Registry Office, Deputy of Health, Abidar Street, Sanandaj, Iran.
Haidar NadrianFaculty of Health Sciences, Department of Health Education and Promotion, Tabriz University of Medical Sciences, Tabriz, Iran.
Athareh NajafiDepartment of Nursing, School of Nursing and Midwifery, Islamic Azad University-Sanandaj Branch, Sanandaj, Iran. rosenajafi8@gmail.com.

Funding

Islamic Azad University-Sanandaj Branch 1.2926
6 · The paper itself

Abstract

purposeEven though Kurdistan, the western province of Iran, has a cancer surveillance system, a detailed analysis of incidence rate has not been yet performed. We describe Age Standardized Incidence Rates (ASRs) for esophageal cancer (EC) in Kurdistan Province of Iran in 2001-2015.

methodsIncidence cases of EC were obtained from a population-based cancer registry. We obtained ASRs and 95% confidence intervals (CI) per 100,000 populations for each calendar year group.

resultsBetween 2001 and 2015, 1362 incidence cases with EC were reported to the cancer registry. Annual ASRs in 2006-2010 were more than the other years in both men and women, respectively. Most ASRs were reported among women in Divandarreh (18.95, 95% CI 14.76, 23.92), Saqez (12.75, 95% CI 10.73, 15.01), Sanandaj (8.84, 95% CI 7.64, 10.17), and Qorveh (8.19, 95% CI 6.54, 10.12), and among men in Divandarreh (19.38, 95% CI 15.38, 24.06), Saqez (13.64, 95% CI 11.49, 16.05), Sanandaj (8.70, 95% CI 7.56, 9.96), and Marivan (7.93, 95% CI 6.26, 9.88).

conclusionsIt was concluded that EC in Divandarreh, Saqez, and Sanandaj has the highest ASRs, and these areas are considered as high-risk areas for this disease in the Iranian province of Kurdistan. Therefore, to understand the reasons of these problems, a considerable work is needed.

Indexed as

Population SurveillanceAdultAgedAged, 80 and overAge FactorsEsophageal NeoplasmsFemaleFollow-Up StudiesHumansIncidenceIranMaleMiddle AgedPrognosisRegistriesTime FactorsCancerEsophagealIncidenceIranKurdistan

Identifiers

PMID29744671

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.